Phase 3 ADHD Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 3
Benefits of ADHD Treatment in Detained People
ADHD
Stéphanie Baggio150 enrolled1 locationNCT05842330
Recruiting
Phase 3
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
AnxietySocial Anxiety DisorderADHD+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc.308 enrolled47 locationsNCT06973577
Recruiting
Phase 2Phase 3
Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.630 enrolled1 locationNCT06931080
Recruiting
Phase 3
A Long-term Trial of EB-1020 in Adult Patients With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.180 enrolled1 locationNCT06926829
Recruiting
Phase 3
EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders
Adult ADHDAdult-onset ADHD With Mood Disorder
University Hospital, Strasbourg, France80 enrolled1 locationNCT05832489
Recruiting
Phase 3
Role of Coenzyme Q in ADHD in Children
ADHD
Sherief Abd-Elsalam40 enrolled1 locationNCT04216186
Completed
Phase 3
Imaging the influence and interaction of genes and stimulant medication on attention in Attention Deficit Hyperactivity Disorder (ADHD).
Attention Deficit Hyperactivity Disorder (ADHD)
Dr. Tim Silk60 enrolled1 locationACTRN12610000652077